GC Cell Corporation

KOSDAQ:A144510 Stock Report

Market Cap: ₩377.2b

GC Cell Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

James Park

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership0.1%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

Oct 14
Revenues Working Against GC Cell Corporation's (KOSDAQ:144510) Share Price

Is GC Cell (KOSDAQ:144510) A Risky Investment?

Sep 08
Is GC Cell (KOSDAQ:144510) A Risky Investment?

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

Mar 19
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Feb 22
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Jan 18
Can Green Cross Lab Cell Corporation (KOSDAQ:144510) Improve Its Returns?

Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

Dec 14
Can You Imagine How Jubilant Green Cross Lab Cell's (KOSDAQ:144510) Shareholders Feel About Its 139% Share Price Gain?

CEO

James Park (58 yo)

no data

Tenure

Mr. James Park is Chairman of the Board of BioCentriq, Inc and was its Interim CEO. He had been a Director of Artiva Biotherapeutics, Inc. since January 2023 until July 2024. He served as Executive VP at S...